ALTERATIONS IN C3, C4, FACTOR-B, AND RELATED METABOLITES IN SEPTIC SHOCK

被引:34
作者
LIN, RY [1 ]
ASTIZ, ME [1 ]
SAXON, JC [1 ]
SAHA, DC [1 ]
RACKOW, EC [1 ]
机构
[1] ST VINCENTS HOSP & MED CTR,NEW YORK MED COLL,DEPT MED,CRIT CARE MED SECT,NEW YORK,NY 10011
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1993年 / 69卷 / 02期
关键词
D O I
10.1006/clin.1993.1161
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Forty subjects consisting of (i) patients with septic shock, (ii) patients with sepsis without shock, (iii) critically ill nonseptic patients, and (iv) normal controls were studied for plasma C3, C4, factor B, iC3b, C4d, Bb, and SC5b-9 levels in an attempt to profile the pattern of complement activation in sepsis. Significant decreases in plasma C3 and C4 concentrations were observed in septic shock patients compared to normal as well as to critically ill subjects. When adjusted for illness severity, levels of C3 but not C4 showed significant differences between septic shock and critically ill patients. Concentrations of the complement metabolite Bb as well as the Bb to factor B ratio were significantly increased in septic shock patients. SC5b-9 levels were significantly higher in septic shock patients compared to normal as well as to critically ill subjects. No increases in C4d or iC3b were observed, but the iC3b to C3 ratio was higher in septic shock patients compared to that in normal subjects. In septic shock patients, there were significant correlations between SC5b-9 and Bb (P = 0.0213) concentrations and between C3 and Factor B concentrations (P = 0.0041). SC5b-9 levels also were correlated with lactate levels in septic shock patients (P = 0.0091). These findings demonstrate a metabolite pattern consistent with primarily alternative and terminal pathway activation in septic shock patients. Decreases in C4, a classical pathway component, may not be specific for septic shock and do not appear to be necessarily due to significant complement consumption/activation. © 1993 Academic Press, Inc.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 39 条
[1]   THE ACTIVATION OF POLYMORPHONUCLEAR NEUTROPHILS AND THE COMPLEMENT-SYSTEM DURING IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 [J].
BAARS, JW ;
HACK, CE ;
WAGSTAFF, J ;
EERENBERGBELMER, AJM ;
WOLBINK, GJ ;
THIJS, LG ;
VANSCHIJNDEL, RJMS ;
VANDERVALL, HLJA ;
PINEDO, HM .
BRITISH JOURNAL OF CANCER, 1992, 65 (01) :96-101
[2]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[3]  
BROWN EJ, 1988, IMMUNOLOGICAL DISEAS, P715
[4]  
CARVALHO AC, 1988, J LAB CLIN MED, V112, P270
[5]   COMPLEMENT LEVELS IN PNEUMOCOCCAL PNEUMONIA [J].
COONROD, JD ;
RYLKOBAUER, B .
INFECTION AND IMMUNITY, 1977, 18 (01) :14-22
[6]   CLINICAL-APPLICATION OF NEW TECHNIQUE THAT MEASURES C4D FOR ASSESSMENT OF ACTIVATION OF CLASSICAL COMPLEMENT PATHWAY [J].
DAVIES, ET ;
NASARUDDIN, BA ;
ALHAQ, A ;
SENALDI, G ;
VERGANI, D .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (02) :143-147
[7]   ACTIVATION OF PROPERDIN PATHWAY OF COMPLEMENT IN PATIENTS WITH GRAM-NEGATIVE BACTEREMIA [J].
FEARON, DT ;
RUDDY, S ;
SCHUR, PH ;
MCCABE, WR .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (18) :937-940
[8]  
Frank MM, 1988, IMMUNOLOGICAL DIS, P203
[9]   ACTIVATION OF COMPLEMENT-SYSTEM DURING INFECTIONS DUE TO GRAM-NEGATIVE BACTERIA [J].
FUST, G ;
PETRAS, G ;
UJHELYI, E .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1976, 5 (03) :293-302
[10]  
GALLINARO R, 1992, SURG GYNECOL OBSTET, V174, P435